ロード中...
Alzheimer’s disease—subcortical vascular disease spectrum in a hospital-based setting: Overview of results from the Gothenburg MCI and dementia studies
The ability to discriminate between Alzheimer’s disease (AD), subcortical vascular disease, and other cognitive disorders is crucial for diagnostic purposes and clinical trial outcomes. Patients with primarily subcortical vascular disease are unlikely to benefit from treatments targeting the AD path...
保存先:
| 出版年: | J Cereb Blood Flow Metab |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publications
2016
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4702291/ https://ncbi.nlm.nih.gov/pubmed/26219595 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/jcbfm.2015.148 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|